JPS61290960A - Blood dialyser - Google Patents

Blood dialyser

Info

Publication number
JPS61290960A
JPS61290960A JP13199085A JP13199085A JPS61290960A JP S61290960 A JPS61290960 A JP S61290960A JP 13199085 A JP13199085 A JP 13199085A JP 13199085 A JP13199085 A JP 13199085A JP S61290960 A JPS61290960 A JP S61290960A
Authority
JP
Japan
Prior art keywords
hollow fiber
ufr
membrane
protrusions
clu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13199085A
Other languages
Japanese (ja)
Other versions
JPH0530466B2 (en
Inventor
水谷 昭治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP13199085A priority Critical patent/JPS61290960A/en
Priority to CA494836A priority patent/CA1272139C/en
Priority to DE3588092T priority patent/DE3588092T2/en
Priority to EP89100842A priority patent/EP0321447B1/en
Priority to DE3587795T priority patent/DE3587795T2/en
Priority to EP85308220A priority patent/EP0186293B1/en
Priority to US06/796,865 priority patent/US4781833A/en
Priority to EP89100843A priority patent/EP0321448B1/en
Priority to DE3587787T priority patent/DE3587787T2/en
Publication of JPS61290960A publication Critical patent/JPS61290960A/en
Priority to US07/477,174 priority patent/US5063009A/en
Publication of JPH0530466B2 publication Critical patent/JPH0530466B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 [利用分野] 。[Detailed description of the invention] [Field of use].

本発明は中空糸型の血液透析器に関するものである。さ
らに詳しくは、外周部に突起を有する異形中空膜を内蔵
した中空糸型血液透析器に関するものである。
The present invention relates to a hollow fiber type hemodialyzer. More specifically, the present invention relates to a hollow fiber hemodialyzer having a built-in irregularly shaped hollow membrane having protrusions on its outer periphery.

[従来技術] 腎不全患者の血液を浄化し、余剰の水分を除去するため
に、血液透析器が使用されている。これは容器の中に透
析膜例えば中空糸膜を多数本収納し、その中空内部に患
者の血液を流し、外部即ち中空糸膜間に透析液を流して
、中空糸膜を介して透析によって血液中の老廃物を除去
し、電解質濃度を調整すると共に、中空糸膜内外に圧力
差を与え、限外濾過によって血液中の余剰水分を除去す
るものである。
[Prior Art] Hemodialyzers are used to purify the blood of renal failure patients and remove excess water. In this system, a large number of dialysis membranes, such as hollow fiber membranes, are housed in a container, and the patient's blood is poured into the hollow interior of the container, and the dialysate is poured outside, that is, between the hollow fiber membranes, and the blood is dialyzed through the hollow fiber membranes. In addition to removing waste products and adjusting the electrolyte concentration, a pressure difference is applied between the inside and outside of the hollow fiber membrane, and excess water in the blood is removed by ultrafiltration.

透析器の最も重要な性能である透析性能について従来よ
り各種の工夫がなされ改善が行われてきた。例えば、中
空糸膜の膜厚をうすくしたり、有効膜面積を増大させる
などの方法がとられている。
Various efforts have been made to improve the dialysis performance, which is the most important performance of a dialyzer. For example, methods such as reducing the thickness of the hollow fiber membrane or increasing the effective membrane area have been taken.

とくに、中空糸膜の膜厚をうすくすれば、単位面積あた
りの透析性能が向上して、透析器を小型化できるという
利点がある。透析器の基本性能は、クリアランス即ち老
廃物除去性(以下Cと記す)と限外濾過性即ち除水性(
以下Fと記す)によって表わすことができる。透析膜の
膜厚をうすくすると、単位面積あたりのFは加速度的に
増大するのに対して、Cは徐々にしか増大しない。その
結果、Cを実用上適当な範囲に入れようとすると、Fは
適当な範囲をこえることになり、このような中空糸膜を
収納した透析器は、そのままでは使いにくく、例えば除
水性能を制御しつる他の装置を併用するなどの工夫が必
要となる。また、有効膜面積を増加して透析器の性能を
向上させようとすれば、Fはほぼ面積に比例して増大す
るのに対して、Cは徐々に増大して一定値に収斂し、膜
厚を薄くすると同じような問題が発生する。何れにして
も、中空糸膜の膜厚がある程度薄く、しかも膜面積があ
る程度大きい透析器に於て、FとCとのバランスを実用
上適当な範囲におさめることは、困難であることが多か
った。
In particular, reducing the thickness of the hollow fiber membrane has the advantage of improving dialysis performance per unit area and making it possible to downsize the dialyzer. The basic performance of a dialyzer is clearance, or waste removal (hereinafter referred to as C), and ultrafiltration, or water removal (
(hereinafter referred to as F). When the thickness of the dialysis membrane is reduced, F per unit area increases at an accelerated rate, whereas C increases only gradually. As a result, if we try to keep C within a practically appropriate range, F will exceed the appropriate range, and dialyzers containing such hollow fiber membranes are difficult to use as they are, and, for example, water removal performance may be affected. It is necessary to devise measures such as using other control devices together. Furthermore, if an attempt is made to improve the performance of a dialyzer by increasing the effective membrane area, F will increase almost in proportion to the area, while C will gradually increase and converge to a constant value, A similar problem occurs when the thickness is reduced. In any case, it is often difficult to keep the balance between F and C within an appropriate range for practical use in dialyzers in which the hollow fiber membrane has a certain thin thickness and a certain large membrane area. Ta.

[発明の目的] 本発明の目的は、かかる問題点を解決し、透析性能がす
ぐれ、とくに老廃物除去性と除水性とのバランスの良好
な血液透析器を提供することにある。本発明の他の目的
は、安定に且つ容易に製造され得る突起つき中空糸膜を
収納した高性能で且つ小型の血液透析器を提供すること
にある。
[Object of the Invention] An object of the present invention is to solve the above problems and provide a hemodialyzer with excellent dialysis performance and particularly a good balance between waste removal performance and water removal performance. Another object of the present invention is to provide a high-performance, small-sized hemodialyzer housing a hollow fiber membrane with protrusions that can be stably and easily manufactured.

[発明の構成] 本発明は、選択透過性中空糸、Illの集束体を容器に
収納した中空糸型血液透析器において、該中空糸膜の大
部分が外周部に長手方向に沿って延長された2条以上の
突起を有する異形断面中空糸膜であり、該透析器の全有
効躾面積S [Tdl 、限外濾過性能UFR[ae/
m−hr・膳Hg]及び尿素クリアランスCLLI [
se/sin ]が下記式(1)〜([[)のいずれか
を満たすことを特徴とする血液透析器 0.5≦S≦ 1.0のとき tJFR/S≦6.CLtJ/UFR≧30・・・(I
)1.0< S≦ 1.6のとき LIFR/S≦5.CLU/UFR≧30・・・(II
)1.6<S≦ 2.5のとき UFR/S≦4.CLLJ/LJFR≧25・・・(I
II)を提供するものである。
[Structure of the Invention] The present invention provides a hollow fiber type hemodialyzer in which a bundle of permselective hollow fibers, Ill, is housed in a container, in which most of the hollow fiber membranes extend along the longitudinal direction on the outer periphery. It is a hollow fiber membrane with an irregular cross section having two or more protrusions, and the total effective area of the dialyzer S [Tdl, ultrafiltration performance UFR [ae/
m-hr・zen Hg] and urea clearance CLLI [
se/sin ] satisfies any of the following formulas (1) to ([[)] When 0.5≦S≦1.0, tJFR/S≦6. CLtJ/UFR≧30...(I
)1.0<S≦1.6, LIFR/S≦5. CLU/UFR≧30...(II
) When 1.6<S≦2.5, UFR/S≦4. CLLJ/LJFR≧25...(I
II).

更に好ましいものとして、セルロースから成り、突起部
を除く部分の膜厚が30μ以下、有効膜面積が0.57
F1以上である上記血液透析器および、セルロース・エ
ステル又はポリメチルメタクリレート。
More preferably, it is made of cellulose, has a film thickness of 30μ or less excluding the protrusions, and has an effective film area of 0.57.
The above-mentioned hemodialyzer and cellulose ester or polymethyl methacrylate which is F1 or higher.

ポリエチレン・ポリビニルアルコール・コポリマー、ポ
リアクリロニトリル、ポリカーボネート。
Polyethylene polyvinyl alcohol copolymer, polyacrylonitrile, polycarbonate.

ポリスルフォンなどの半合成ないし合成高分子かな成り
、突起部を除く膜厚が50μ以下であり、有効膜面積が
0.71d以上である上記の血液透析器を提供するもの
である。
The present invention provides the above-mentioned hemodialyzer, which is made of semi-synthetic or synthetic polymer such as polysulfone, has a membrane thickness of 50 μm or less excluding protrusions, and has an effective membrane area of 0.71 d or more.

以下、本発明について詳細に説明する。本発明の最大の
眼目は、外周部に、長さ方向に沿って連続した突起を有
する異型中空糸膜を使用し、これにもとづいてより優れ
た性能の透析器を得ることである。中空の外周部の突起
は、中空糸どうしの密着を防ぎ、中空糸間を流れる透析
液の潅流効率を向上させ、透析液側の境膜抵抗を減少さ
せる。
The present invention will be explained in detail below. The main feature of the present invention is to use an atypical hollow fiber membrane having continuous protrusions along its length on the outer periphery, and to obtain a dialyzer with superior performance based on this. The protrusions on the hollow outer periphery prevent the hollow fibers from coming into close contact with each other, improve the perfusion efficiency of the dialysate flowing between the hollow fibers, and reduce membrane resistance on the dialysate side.

Cは当該物質の血液中の濃度を透析液中のi3m度との
差に関係するから、透析液側の境膜抵抗即ち透析膜付近
での濃度が減少すれば、それだけCは増大することにな
る。一方、Fは膜面積に比例する。
C is related to the difference between the concentration of the substance in the blood and the i3m degree in the dialysate, so if the membrane resistance on the dialysate side, that is, the concentration near the dialysis membrane, decreases, C will increase accordingly. Become. On the other hand, F is proportional to the membrane area.

その膜面積は、通常の中空糸膜に比べて突起のある部分
だけ実質的に少ない。また突起があるために、血液透析
器用の容器に収納しつる中空糸の本数、従って膜面積は
減少する。即ち、中空糸膜の外周に突起を設けることに
よって、透析液の潅流効率の影響をうけるCは、これら
のハンプキャップを打ち消して増大するにも拘らず、F
は逆に低下するのである。中空糸の本数の減少によって
、血液速度が上昇することも、Cを増大させる方向に働
く。その結果、CとFとを実用上好ましい範囲にバラン
スさせることが極めて容易になることを本発明者が鋭意
研究の結果見出し本発明に到達した。
The membrane area is substantially smaller than that of a normal hollow fiber membrane in the area where the protrusions are present. The presence of the protrusions also reduces the number of hollow fibers that can be accommodated in a hemodialyzer container, and thus the membrane area. That is, by providing protrusions on the outer periphery of the hollow fiber membrane, C, which is affected by the perfusion efficiency of dialysate, cancels out these hump caps and increases;
On the contrary, it decreases. An increase in blood velocity due to a decrease in the number of hollow fibers also works in the direction of increasing C. As a result, the inventor of the present invention discovered through intensive research that it is extremely easy to balance C and F within a practically preferable range, and arrived at the present invention.

即ち本発明は、2条以上の突起を有した異形断面中空糸
膜を主体とした、好ましくは突起付中空糸膜のみからな
る集束体を充填して成形された血液透析器であり、該透
析器の全有効膜面積に応じた透水性を有する該突起付中
空糸膜を用いたものであって前記(I)〜(III)の
いずれかの関係を満たすことを特徴とする透析器を提供
するものである。尚前記式(I)〜(II)で古う全有
効膜面積Sは透析に有効な中空糸膜の内表面であって突
起部の根元に相当する透析に有効でない部分は除いた面
の総和を意味し、限外濾過性能UFR及び尿素クリアラ
ンスCLUは昭和57年9月の日本人工臓器学会ダイア
ライザー性能評価基準により測定して得られる値を意味
する。即ちUFRは循環法で測定し、B液及びD液を循
環させ、B液の10分間の減少容昂から濾過流量を求め
る。B液。
That is, the present invention is a hemodialyzer that is formed by filling a bundle consisting mainly of hollow fiber membranes with irregular cross-sections having two or more protrusions, preferably consisting only of hollow fiber membranes with protrusions. Provided is a dialyzer, which uses the hollow fiber membrane with protrusions and has water permeability corresponding to the total effective membrane area of the device, and which satisfies any of the relationships (I) to (III) above. It is something to do. In addition, the total effective membrane area S used in the above formulas (I) to (II) is the sum of the inner surface of the hollow fiber membrane that is effective for dialysis, excluding the part that is not effective for dialysis and corresponds to the base of the protrusion. The ultrafiltration performance UFR and urea clearance CLU mean values obtained by measurement according to the dialyzer performance evaluation standards of the Japan Society for Artificial Organs dated September 1980. That is, UFR is measured by a circulation method, in which liquid B and liquid D are circulated, and the filtration flow rate is determined from the reduced volume of liquid B over 10 minutes. B liquid.

D液の温度は31±1℃でそれぞれ入口流量は200±
41d/Sin 、  500±10d/winの条件
で測定された場合の値である。またCLUは約37℃に
おいて中空糸内で0.1重量%の尿素水溶液を平均流速
約1.2n / seaで流し中空糸外に平均流速約1
.8ax / secで水を流すことによって測定した
値を意味する。
The temperature of liquid D is 31±1℃, and the inlet flow rate is 200±
This value is measured under the conditions of 41d/Sin and 500±10d/win. In addition, CLU allows a 0.1% by weight aqueous urea solution to flow inside the hollow fiber at an average flow rate of about 1.2 n/sea at about 37°C and out of the hollow fiber at an average flow rate of about 1.
.. Means the value measured by flowing water at 8ax/sec.

従来の中空糸膜で、単に膜厚を薄くしたり、膜面積を増
大したりして、透析性能を向上させるときに、上記の条
件をみたすことは困難であったのに対して、本発明にか
かる異型断面糸では、上記の条件をみたすように透析器
を設計することは、極めて容易である。
With conventional hollow fiber membranes, it was difficult to satisfy the above conditions when improving dialysis performance by simply reducing the membrane thickness or increasing the membrane area. It is extremely easy to design a dialyzer to meet the above conditions using threads with such irregular cross-sections.

本発明の血液透析器は、S、UFR,CLUが前記式(
I)〜(III)のいずれかを満たすものであり、UF
R/Sが各式の上限を超える場合、特に6を超える場合
には透析の際に除水をコントロールすることが困難とな
り、しばしば除水過多をひきおこす。またCLU/UF
Rが式(I)〜(1)の各下限よりも小さい場合、特に
25未満の場合には透析の効果を十分に発揮しえず、老
廃物が漸次体内に蓄積して、いわゆるアンダーダイヤリ
ンスの原因となる。
The hemodialyzer of the present invention has S, UFR, and CLU of the above formula (
I) to (III), and UF
When R/S exceeds the upper limit of each formula, especially when it exceeds 6, it becomes difficult to control water removal during dialysis, often resulting in excessive water removal. Also CLU/UF
When R is smaller than each lower limit of formulas (I) to (1), especially when it is less than 25, the effect of dialysis cannot be fully demonstrated, and waste products gradually accumulate in the body, resulting in so-called underdialysis. It causes

本発明は、CとFがアンバランスとなりがち中空糸膜の
膜厚がうすい場合及び有効膜面積が大きい場合において
とくに有効である。
The present invention is particularly effective when the hollow fiber membrane is thin and the effective membrane area is large, where C and F tend to be unbalanced.

即ち、中空糸膜素材が(A)tフルロースにあっては、
突起部を除く部分の膜厚は30μ以下、(B)セルロー
ス、エステル又はポリメチルメタクリレート、ポリエチ
レン・ポリビニルアルコール・コポリマー、ポリアクリ
ロニトリル、ポリカーボネート、ポリスルフォン(ポリ
ニー乎ルアオンも含む)などの半合成ないし合成高分子
にあっては、突起部を除く部分の膜厚は50μ以下であ
ることがのぞましい。これよりも厚い場合には、性能バ
ランスの点から云えば、本発明のような突起をつける必
要がない代りに、透析性能が低く、透析器のサイズも極
めて大型なものとなる。また、膜面積については、上記
(A)の場合にあっては0.5Td以上、(B)の場合
にあっては0.1d以上であることが好ましい。
That is, when the hollow fiber membrane material is (A) t-fluulose,
The film thickness at the part excluding the protrusions is 30μ or less. (B) Semi-synthetic or synthetic material such as cellulose, ester or polymethyl methacrylate, polyethylene/polyvinyl alcohol copolymer, polyacrylonitrile, polycarbonate, polysulfone (including polynylon) In the case of polymers, it is desirable that the film thickness of the portion excluding the protrusions is 50 μm or less. If it is thicker than this, from the point of view of performance balance, there is no need to provide protrusions as in the present invention, but the dialysis performance will be low and the size of the dialyzer will be extremely large. Furthermore, the membrane area is preferably 0.5 Td or more in the case of (A) above, and 0.1 d or more in the case of (B).

さらに前記式(I)〜(DI)を満たす本発明の血液透
析器において、UFRが3.5以上であれば老廃物除去
性を保持したまま除水性を高い水準に維持し得るので好
ましく、更にtJ F、、Rが4.0以上であることが
好ましく、特に5.0以上であることが望ましい。まb
該血液透析器においてCLUが160以上であれば除水
性を保持した状態で且つ尿素で代表される老廃物の除去
率が高い水準に維持し得ることが容易であり、さらにC
LtJが170以上であることが望ましい。
Further, in the hemodialyzer of the present invention that satisfies the above formulas (I) to (DI), it is preferable that the UFR is 3.5 or more because water removal performance can be maintained at a high level while maintaining waste product removal performance; tJ F,, R is preferably 4.0 or more, particularly preferably 5.0 or more. Mab
If the hemodialyzer has a CLU of 160 or more, it is easy to maintain water removal properties and the removal rate of waste products represented by urea at a high level.
It is desirable that LtJ is 170 or more.

本発明の透析器に用いられる中空糸膜の突起の数は、2
〜10条が好ましく、更に2〜8条が適当である。11
以上になると突起の根元部による有効膜面積の減少が顕
著になり1、老廃物の除去性及び除水性が低下して実用
的でない。その突起数の特に有効な範囲は3〜8であ、
る。さらに該中空糸膜の外径は100〜400μが好ま
しく、突起部を除く部分の膜厚は前記(A)の場合には
5〜30μが好ましく(B)場合には10〜50μが好
ましい。また突起部の高さは5〜80μ、さらには10
〜50μがこのましく、さらに該突起部の巾は15〜5
0μ、好ましくは20〜40μのものが適当である。こ
の様な範囲にある中空糸は真円性が良好であり中空糸内
での血液凝固や残血が生じにくい点でも好ましい。
The number of protrusions on the hollow fiber membrane used in the dialyzer of the present invention is 2.
-10 articles are preferred, and 2-8 articles are more appropriate. 11
If this is the case, the effective membrane area at the base of the protrusion will be significantly reduced (1), and the ability to remove waste products and water will be reduced, making it impractical. A particularly effective range of the number of protrusions is 3 to 8,
Ru. Further, the outer diameter of the hollow fiber membrane is preferably 100 to 400μ, and the thickness of the membrane excluding the protrusions is preferably 5 to 30μ in the case of (A) and 10 to 50μ in the case of (B). In addition, the height of the protrusion is 5 to 80 μm, and even 10 μm.
~50μ is preferable, and the width of the protrusion is preferably 15~50μ.
A suitable value is 0μ, preferably 20 to 40μ. Hollow fibers within this range are preferable because they have good circularity and are less likely to cause blood coagulation or residual blood within the hollow fibers.

中空糸膜素材については、とくに限定するものではない
がCLLJに対してUFRが大きくなりやすいセルロー
ス・アセテート、ポリメチルメタクリレート、ポリエチ
レン・ポリビニルアルコール・コポリマー、ポリアクリ
ロニトリル、ポリカーボネート、ポリスルフォンなどの
半合成ないし合成高分子膜の場合にとくに有効である。
Hollow fiber membrane materials are not particularly limited, but include semi-synthetic or semi-synthetic materials such as cellulose acetate, polymethyl methacrylate, polyethylene polyvinyl alcohol copolymer, polyacrylonitrile, polycarbonate, and polysulfone, which tend to have a large UFR relative to CLLJ. This is particularly effective in the case of synthetic polymer membranes.

本発明の血液透析器は、かかる突起を有した中空糸膜を
全有効面積を考慮して充填せしめたものであるが、突起
を有さない中空糸膜を例えば10%以下の割合で少ff
1i!2人せしめて充填することも可能である。該血液
透析器における中空糸膜の充填率としては30〜80%
の範囲が好ましく、更に40〜70%の範囲であれば前
記式(I)〜(IIりを満たしたものが確実に製造でき
るので好ましい。
The hemodialyzer of the present invention is filled with hollow fiber membranes having such protrusions taking into account the total effective area, but hollow fiber membranes having no protrusions are filled with a small amount of, for example, 10% or less.
1i! It is also possible to fill the tank with at least two people. The filling rate of the hollow fiber membrane in the hemodialyzer is 30 to 80%.
A range of 40 to 70% is preferable, and a range of 40 to 70% is more preferable because products satisfying the above formulas (I) to (II) can be reliably produced.

[実施例] 以下、本発明の内容、効果について実施例により説明を
するが、本発明はこれらによって何ら限定されるもので
はない。
[Examples] Hereinafter, the content and effects of the present invention will be explained using examples, but the present invention is not limited by these in any way.

実施例1〜9.比較例1〜3 セルロースジアセテート 100部に対し、ポリエチレ
ングリコール(分子1400)を45部加えたものを混
合し、その混合物を220℃で溶融し、丸型及び突起付
用の中空糸口金を用いて°紡出し、次いで苛性ソーダで
セルロースに鹸化後、巻取った。
Examples 1-9. Comparative Examples 1 to 3 100 parts of cellulose diacetate was mixed with 45 parts of polyethylene glycol (molecular weight: 1400), the mixture was melted at 220°C, and a round mold and a hollow fiber cap with protrusions were used. The material was then spun, then saponified to cellulose with caustic soda, and then wound up.

その時の突起のない部分の中空糸の膜厚(湿潤時)及び
突起の数は表1の如くでありこれは紡糸時の口金種類及
び吐出量により調節した。得られたセルロース中空糸を
各種の大きさの容器に収納し1nVitrOでのUFR
及び尿素のクリアンスを測定した。その結果は表1に示
す如くである。ここでUFR,クリアランスCLUの測
定法は人工臓器学会の基準に基づく。明らかに本発明に
よる実施例では透析器が小面積でかつ、クリアランスが
高く又LJFRが適当なものになっていることがわかる
The film thickness (when wet) of the hollow fiber in the part without projections and the number of projections are as shown in Table 1, and these were adjusted by the type of die and the discharge rate during spinning. The obtained cellulose hollow fibers were stored in containers of various sizes and subjected to UFR at 1nVitrO.
and urea clearance was measured. The results are shown in Table 1. Here, the methods for measuring UFR and clearance CLU are based on the standards of the Society for Artificial Organs. It is clearly seen that in the embodiment according to the present invention, the dialyzer has a small area, a high clearance, and an appropriate LJFR.

即ちUFRとクリアランスのバランスが適当でかつ高性
能になっている。
In other words, the balance between UFR and clearance is appropriate and high performance is achieved.

実施例10.比較例4.5 実施例1と同様にしで、表1に合せて示す中空糸を製造
し、その各々を用いて有効面積が0.8d及び0.4コ
の血液透析器を作成した。その透析器を用いてin v
ttroで性能を測定したところ、表1に示す結果が得
られた。即ち比較例4.5で示される如く突起のない中
空糸で膜厚35μのもの及び6条の突起付中空糸でも0
.4麓のちのでは透析性能が低く実用的でない。
Example 10. Comparative Example 4.5 Hollow fibers shown in Table 1 were manufactured in the same manner as in Example 1, and hemodialyzers with effective areas of 0.8 d and 0.4 d were created using each hollow fiber. In v using the dialyzer
When performance was measured using ttro, the results shown in Table 1 were obtained. That is, as shown in Comparative Example 4.5, a hollow fiber without protrusions with a film thickness of 35 μm and a hollow fiber with 6 protrusions also showed zero
.. Dialysis performance after the 4th foot is so low that it is not practical.

実施例11及び比較例6〜7 セルロースジアセテート 100部に対し、ポリエチレ
ングリコール及びジグリセリンを140部混白し、その
混合物を200℃で溶融し、丸型及び突起併用中空糸口
金を用いて紡糸し、次いで熱水で可塑剤を抽出後、各極
大きさのケースに中空糸を充填し、in V+trO性
能を測定した。結果は表1の如くであり、膜厚55μで
突起などのもの及び6ケの突起付中空糸で面積0.6T
dのものは透析性能が低く実用に適しないことが明らか
である。
Example 11 and Comparative Examples 6 to 7 140 parts of polyethylene glycol and diglycerin were mixed with 100 parts of cellulose diacetate, the mixture was melted at 200°C, and spun using a round and protruded hollow fiber die. Then, after extracting the plasticizer with hot water, hollow fibers were filled into cases of each pole size, and in V+trO performance was measured. The results are shown in Table 1, and the area is 0.6T with a film thickness of 55 μm, a hollow fiber with protrusions, etc., and 6 protrusions.
It is clear that d has low dialysis performance and is not suitable for practical use.

(以下余白) 表1 [発明の効果] 本発明により、透析性能がすぐれ、とくに老廃物除去性
と除水性とのバランスの良好な透析器を提供できるよう
になった。同時に透析器の小型化が可能となり、製造コ
ストの低減、使用運搬の簡便性、更には今後の傾向とし
て注目される短時間透析への大きな員献が期待されるも
のである。
(The following is a blank space) Table 1 [Effects of the Invention] The present invention has made it possible to provide a dialyzer with excellent dialysis performance and particularly a good balance between waste removal performance and water removal performance. At the same time, it is possible to make dialyzers smaller, which is expected to reduce manufacturing costs, simplify use and transportation, and further contribute to short-term dialysis, which is attracting attention as a future trend.

Claims (1)

【特許請求の範囲】 (1)選択透過性中空糸膜の集束体を容器に収納した中
空型血液透析器において、該中空糸膜の大部分が外周部
に長手方向に沿って延長された2条以上の突起を有する
異形断面中空糸膜であり、該透析器の全有効膜面積S[
m^2]、限外濾過性能UFR[ml/m^2・hr・
mmHg]及び尿素クリアランスCLU[ml/min
]が下記式( I )〜(III)のいずれかを満たすことを
特徴とする血液透析器。 0.5≦S≦1.0のとき UFR/S≦6、CLU/UFR≧30・・・( I )
1.0<S≦1.6のとき UFR/S≦5、CLU/UFR≧30・・・(II)1
.6<S≦2.5のとき UFR/5≦4、CLU/UFR≧25・・・(III)
(2)該異形断面中空糸膜が主としてセルロースからな
り、その湿潤時における突起部以外の膜厚が30μ以下
である特許請求の範囲第1項記載の血液透析器。 (3)該異形断面中空糸膜が、主としてセルロースエス
テル、ポリメチルメタクリレート、ポリエチレン・ポリ
ビニルアルコール・コポリマー、ポリアクリロニトリル
、ポリカーボネート、ポリスルフォンからなる群から選
ばれる少なくとも一種からなり、その湿潤時の突起部以
外の膜厚が50μ以下である特許請求の範囲第1項記載
の血液透析器。
[Scope of Claims] (1) A hollow hemodialyzer in which a bundle of permselective hollow fiber membranes is housed in a container, in which most of the hollow fiber membranes extend along the longitudinal direction at the outer periphery. It is a hollow fiber membrane with an irregular cross section having protrusions of more than one strip, and the total effective membrane area of the dialyzer S[
m^2], ultrafiltration performance UFR [ml/m^2・hr・
mmHg] and urea clearance CLU [ml/min
] satisfies any of the following formulas (I) to (III). When 0.5≦S≦1.0, UFR/S≦6, CLU/UFR≧30...(I)
When 1.0<S≦1.6, UFR/S≦5, CLU/UFR≧30...(II)1
.. When 6<S≦2.5, UFR/5≦4, CLU/UFR≧25...(III)
(2) The hemodialyzer according to claim 1, wherein the irregular cross-section hollow fiber membrane is mainly made of cellulose and has a thickness of 30 μm or less other than the protruding portions when wet. (3) The irregular cross-section hollow fiber membrane is mainly made of at least one selected from the group consisting of cellulose ester, polymethyl methacrylate, polyethylene/polyvinyl alcohol copolymer, polyacrylonitrile, polycarbonate, and polysulfone, and the protrusions when wetted The hemodialyzer according to claim 1, wherein the other membrane thicknesses are 50 μm or less.
JP13199085A 1984-11-16 1985-06-19 Blood dialyser Granted JPS61290960A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP13199085A JPS61290960A (en) 1985-06-19 1985-06-19 Blood dialyser
CA494836A CA1272139C (en) 1984-11-16 1985-11-07 Fluid separator, hollow fiber to be used for construction thereof and process for preparation of said hollow fibers
EP85308220A EP0186293B1 (en) 1984-11-16 1985-11-12 Blood treatment device
EP89100842A EP0321447B1 (en) 1984-11-16 1985-11-12 Cellulose type hollow fibers
DE3587795T DE3587795T2 (en) 1984-11-16 1985-11-12 Hollow cellulose fibers.
DE3588092T DE3588092T2 (en) 1984-11-16 1985-11-12 Blood treatment device
US06/796,865 US4781833A (en) 1984-11-16 1985-11-12 Hollow fiber fluid separator
EP89100843A EP0321448B1 (en) 1984-11-16 1985-11-12 Process for preparation of hollow fibers
DE3587787T DE3587787T2 (en) 1984-11-16 1985-11-12 Process for the production of hollow fibers.
US07/477,174 US5063009A (en) 1984-11-16 1990-01-26 Process for preparation of hollow fibers for fluid separator construction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13199085A JPS61290960A (en) 1985-06-19 1985-06-19 Blood dialyser

Publications (2)

Publication Number Publication Date
JPS61290960A true JPS61290960A (en) 1986-12-20
JPH0530466B2 JPH0530466B2 (en) 1993-05-10

Family

ID=15070974

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13199085A Granted JPS61290960A (en) 1984-11-16 1985-06-19 Blood dialyser

Country Status (1)

Country Link
JP (1) JPS61290960A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5771407A (en) * 1980-10-20 1982-05-04 Terumo Corp Hollow fiber
JPS5850761A (en) * 1981-09-21 1983-03-25 Fujitsu Ltd Semiconductor device
JPS58169510A (en) * 1981-11-27 1983-10-06 Asahi Medical Kk Hollow fiber with modified cross section and hollow fiber module therefrom

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5771407A (en) * 1980-10-20 1982-05-04 Terumo Corp Hollow fiber
JPS5850761A (en) * 1981-09-21 1983-03-25 Fujitsu Ltd Semiconductor device
JPS58169510A (en) * 1981-11-27 1983-10-06 Asahi Medical Kk Hollow fiber with modified cross section and hollow fiber module therefrom

Also Published As

Publication number Publication date
JPH0530466B2 (en) 1993-05-10

Similar Documents

Publication Publication Date Title
US5354470A (en) Porous polypropylene membrane and method for production thereof
KR100432464B1 (en) Polysulfone Hollow Fiber Semipermeable Membrane
JPH06205954A (en) New high flux hollow fiber membrane
WO1997034687A1 (en) Hollow yarn membrane used for blood purification and blood purifier
CA1107467A (en) Polycarbonate membranes for use in hemodialysis
JPS63109871A (en) Blood dialytic membrane
EP0012630B1 (en) Process for producing a cellulose acetate-type permselective membrane, permselective membrane thus produced, and use of such membrane in artificial kidney
US4308145A (en) Relatively thick polycarbonate membranes for use in hemodialysis
JPS61290960A (en) Blood dialyser
JP2002143298A (en) Blood treatment apparatus
JPH09308685A (en) Hollow fiber membrane for blood purification and blood purifying device
JPS6160165B2 (en)
JPS60222112A (en) Hollow yarn-shaped filter and its manufacture
JP2000325763A (en) Production of hollow-fiber membrane for hemocatheresis, and hollow-fiber membrane thereof
JPH0613048B2 (en) Selectively permeable hollow fiber
JP2812890B2 (en) Blood purifier
JP2710711B2 (en) Cellulose diacetate hollow fiber
JP3253885B2 (en) Permselective hollow fiber membrane
JP3253867B2 (en) Permselective hollow fiber membrane
JPS61268304A (en) Fluid separator
JP2000210544A (en) Production of semipermeable membrane
JP3345260B2 (en) Permselective hollow fiber membrane
JP2000107577A (en) Production of permselective hollow fiber membranes
JP3236233B2 (en) Method for producing selectively permeable hollow fiber membrane
JP2710710B2 (en) Fluid separator